%0 Journal Article
%A Del Campo Campos, Cristina
%A Bai, Jiaru
%A Keller,L. Robin
%T Modeling cost-effectiveness analysis of treatment sequencing
%D 2025
%@ 0038-0121
%U https://hdl.handle.net/20.500.14352/120473
%X In clinical practice, patients with cancer often undergo treatment with a sequence of drugs, usually because of diminishing effectiveness over time or resistance development. However, few cost-effectiveness analyses have included that fact in their model. This paper aims at closing that gap by presenting a model that reflects the possibility of the patient switching from one therapeutic agent to another one throughout the long-term duration of his/her life.
%~